Avigan May Be Included in MSF Ebola Drug Trial, Fujifilm Says

Fujifilm Holdings Corp.’s Avigan drug may be included among experimental treatments to be tested by aid group Doctors Without Borders, or MSF, said Takao Aoki, a spokesman for the Tokyo-based company, yesterday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.